SuperworthDefinium Therapeutics market cap DFTX
Share price times shares outstanding: what the whole company sells for, since 2022.
- Today, Oct 23, 2026
- $4.8B
- Highest close in our data
- $6.2B
- Aug 2026
Definium Therapeutics is worth $4.8B at the close on Oct 23, 2026, at $35.67 a share.
That is up 409% over the last year and up 962% over five years.
Its highest close in our data was $6.2B in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $4.8B | $1.3B | $6.2B | +273% |
| 2025 | $1.3B | $409.3M | $1.3B | +156% |
| 2024 | $501.6M | $143.9M | $675.6M | +242% |
| 2023 | $146.7M | $98.1M | $179.5M | +78% |
| 2022 | $82.7M | $75.7M | $451.4M | n/a |
Against its peers
Companies in Chemicals nearest Definium Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| DFTXDefinium Therapeutics | $4.8B |
| CSWCSW Industrials | $4.8B |
| BCPCBalchem | $5.6B |
| HXLHexcel | $6B |
| CBTCabot | $3.8B |
| AVNTAvient | $3.8B |
| EMNEastman Chemical | $7.4B |
| WDFCWD 40 | $2.9B |
| ESIElement Solutions | $8.1B |
| FULFuller H B | $2.7B |
| IOSPInnospec | $2.4B |
| Peer median | $4.3B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Definium Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.